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ABSTRACT 
 
Nature inspires us to address the most contemporary scientific challenges. Advances 
in the drug delivery system at the nano/micro-scale hold promise to treat some fatal diseases 
in the next few decades. Scientists have discovered that the biomolecule Chlorotoxin, a 
naturally occurring biomaterial, can target tumor cells in the human brain with great 
precision. The application of Chlorotoxin can assist future surgeons to avoid the risk of 
damaging healthy tissues in the human brain. Chlorotoxin purified from scorpion venom is 
essentially a peptide containing 36 amino acids and demonstrates high affinity particularly to 
glioma and neuroectodermal tumor. Knowledge of the molecular structure and stability is 
immensely useful to understand transport of Chlorotoxin in a blood saturated environment. 
Equilibrium molecular dynamics simulations are employed to examine the stability of 
Chlorotoxin at various temperatures and ion concentrations of the surrounding solvent 
environment. The analyses of the root mean square deviation, radial distribution function, 
and radius of gyration from the molecule’s atomic trajectories facilitate prediction of the 
structural stability of Chlorotoxin under different thermodynamic environments and the 
optimal temperature and ion concentration for its diffusion in blood.  
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CHAPTER I 
 INTRODUCTION  
 
1.1 Motivation 
 Disease is an obstacle for human civilization, aside from war. Nanoscience and 
nanotechnology holds promise for a possibility to conquer some of these fatal diseases.  In 
particular, nano-bio-technological material and devices are increasingly attracting scientists 
to focus on the pharmaceutical industry.  The general features of a nano-system typically 
require that the system itself or its essential components be man-made in the 1–100 nm range 
in at least one dimension, usually integrating novel material structures for devices and 
systems with fundamentally new properties and functions [1-2].  George Whitesides [3] and 
Robert Langer [4] both suggested that less limitations should be put on the dimension of the 
medicine and instead the interest should be on the function of the system and tools to derive 
it. The investigation of nanoparticles is presently of interest for medical applications due to 
its therapeutic and diagnostic potential. The application of nanoparticles to treat diseases 
encounters two major issues: efficacy and efficiency [5–8]. Specifically, as Theresa pointed 
out that many of the early problems of conventional drugs can be resolved with several 
nanotechnology-based drug delivery systems [6]. For example, the conventional drugs have 
problems such as poor solubility, tissue damage on extravasation, rapid breakdown of the 
drug in vivo, unfavorable pharmacokinetics, poor bio-distribution, and lack of selectivity for 
target tissues [6].  One can also read this information from Table 1 below. Moreover, another 
challenge of treating cancer is the prediction of precancer in an earlier stage [1]. 
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Problem Implication Effect of DDS 
Poor solubility  
 
 
 
 
 
 
A convenient pharmaceutical format is 
difficult to achieve, as hydrophobic 
drugs may precipitate in aqueous 
media. Toxicities are associated with 
the use of excipients such as Cremphor 
(the solubilizer for paclitaxel in Taxol). 
DDS such as lipid micelles or 
liposomes provide both 
hydrophilic and hydrophobic 
environments, enhancing 
drug solubility. 
Tissue damage on  
Extravasation 
 
 
Inadvertent extravasation of cytotoxic 
drugs leads to tissue damage, e.g., 
tissue necrosis with free doxorubicin. 
Regulated drug release from 
the DDS can reduce or 
eliminate tissue damage on 
accidental extravasation. 
 
Rapid breakdown 
of the drug in vivo 
 
Loss of activity of the drug follows 
administration, e.g., loss of activity of 
camptothecins at physiological pH. 
DDS protects the drug from 
premature degradation and 
functions as a sustained 
release system. Lower doses 
of drug are required. 
 
Unfavorable 
Pharmacokinetics 
 
Drug is cleared too rapidly, by the 
kidney, for example, requiring high 
doses or continuous infusion. 
DDS can substantially alter 
the PK of the drug and 
reduce clearance. Rapid renal 
clearance of small molecules 
is avoided. 
Poor distribution 
 
Drugs that have widespread distribution 
in the body can affect normal tissues, 
resulting in dose-limiting side effects, 
such as the cardiac toxicity of 
doxorubicin. 
 
The particulate nature of 
DDS lowers the volume of 
distribution and helps to 
reduce side effects in 
sensitive, nontarget tissues. 
Lack of selectivity 
 for target tissues 
Distribution of the drug to normal 
tissues leads to side effects that restrict 
the amount of drug that can be 
administered. Low concentrations of 
drugs in target tissues will result in 
suboptimal therapeutic effects. 
DDS can increase drug 
concentrations in diseased 
tissues such as tumors by the 
EPR effect. Ligand-mediated 
targeting of the DDS can 
further improve drug 
specificity. 
 
Table 1: Non-ideal properties of drugs and their therapeutic implications.[6] 
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To address the challenges of drug delivery system, it is essential for us to employ the 
novel materials and current nanotechnology, such as experimental tool, imaging tool and 
computational tool to make a breakthrough on the disease treatment. Researchers have 
discovered a reservoir of nanomaterials applied to the drug delivery system, including 
inorganic materials, such as gold, silica, gel and PEG, organic materials such as protein, 
 
Figure 1: Novel materials applied to drug delivery system.  
(Samir Mitragotri, MRS bulletin, volume 39, March 2014) 
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lipids, oxide nanoparticles and so on.[7-8]  Figure 1 lists some of the novel organic 
biomaterials applied to drug delivery system that are under investigation. Those materials 
present special properties and functions corresponding to the demands of drug delivery 
design. Strikingly, one such materials is venom [9–14], a controversial material in nature 
because of its traditional image of poison, driven by the recent discovery of its potential as a 
pharmacological material.  
The most prominent feature of venom is its targeting ability that has emerged after 
thousands of years’ evolution in the process of attacking prey, defending predator, and 
intimidating other species. We have always considered venom as poison or chemical weapon. 
However, derivative venom can be applied to resolve some intriguing medical challenges, 
such as in drug delivery system, analgesic, and tissue engineering [14–16]. In this research, 
we mainly focus on the application of Chlorotoxin (CLTX) to diagnose and treat cancer [15–
20]. Typically, in the literature on CLTX, most of them focus on the application of imaging 
tumor cells for surgeons. The literature [18–20] about imaging applications present us a 
paradigm on how to conjugate CLTX with an imaging agent to target and indicate the tumor 
sites. CLTX is not only useful in the area of imaging, but it also has therapeutic effect to treat 
different diseases apart from cancer. More and more researchers are exploiting the 
therapeutic applications although the advances are still in the early stage. Sontheimer’s group 
[21-22] from the University of Alabama at Birmingham published a few papers about the 
therapeutic mechanism of CLTX treating cancer.  
  Except from the emerging materials available for exploring novel medicine, there is 
an accelerating development on the computational method of drug discovery.  The 
computational method not only provides a physical feeling of the processes at the nanoscale, 
14 
 
 
but it also can enlighten us with details about the reaction mechanisms [23–26] of medicine 
and diseased site by the calculation of binding energies. William L. Jorgensen [26] had 
claimed that proficiency with computations is advantageous for delivering new drug 
candidates more quickly and at lower cost. Specifically, the application of computational 
method to design venom-based derivative drug can resolve the challenges of potential side 
effects due to interactions of toxins with off-target receptors [25]. Gordan [24] has suggested 
that computations have the potential to provide lower cost alternatives for exploring the 
effects of new compounds on ion channels.  
  
 
 
 
 
 
 
 
 
 
 
Nanotechnology is an interdisciplinary field which contains biology, statistical 
mechanics, physics, chemistry, molecular engineering and biotechnology. Accelerated and 
high-throughput screening strategies are required to combine materials and transport 
methodologies for validating the new drugs [27].  
 
Figure 2: Venom extraction from a scorpion to make anti-cancer medicine.  
(http://i.imgur.com/xzu9b.jpg)  
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The venom-derived drug can not only treat some fatal diseases, it also improves the 
drug efficiency in our body [10]. Figure 2 presents the venom extraction from a scorpion that 
is used to make anti-cancer medicine. A complete report on the development of peptide, 
which contains venom and its derivatives, as therapeutic or diagnostic drugs can be requested 
from http://www.peptidetherapeutics.org. Memorial Sloan Keltering Cancer Center also 
demonstrates the application of venom in treating with analgesic, anti-inflammatory, cancer 
treatment, alleviating chemotherapy side effects, immunostimulation and radiation side 
effects. Besides, there are six venom-derived drugs approved by FDA and there are several 
venom drugs in clinical trial. 
1.2 Objective 
There are three fundamental parts comprising the drug delivery system, which are 
platform agent, targeting agent and drug agent. The function of platform agent is to carry out 
other agents in the blood stream and protect other agents from disruption by the protease or 
ions in the blood system; the targeting agent is to locate the diseased site rather than interact 
with normal tissues; the drug agent is to release medicinal drug in a certain amount and 
interact with diseased tissue cells. Table 2 provides a summary of the components of drug 
delivery system. Furthermore, there are other considerations except from those three parts, 
such as  poor solubility, EPR effect, and other side effects.  
 
 
 
 
 
Drug delivery system Function 
Platform agent Carry out and protect other 
agents 
Targeting agent Locate the diseased site instead 
of attaching normal tissues 
Drug agent Interact with bad tissues 
 
Table 2: The three components of drug delivery system 
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Being targeting agent is one of the most prominent features of CLTX. A fundamental 
understanding of CLTX reaction mechanisms with glioma cell membrane can be extended to 
delivery processes of CLTX-based conjugates that constitute the drug circulating in human 
body. Current therapeutic methods of curing cancer always encounter two challenges, the 
efficacy and cytotoxicity. We apply computer-aided drug design (CADD) method to identify 
a potential drug candidate and optimize the discovered drug. Such a drug candidate can be 
useful during surgical applications and chemotherapy, which are two ways to treat glioma 
cells. From a surgery perspective, biomarker such a CLTX-Cy5.5 nano-probe [21- 22] could 
potentially be used to image resections of glioma brain tumors. From chemotherapy 
standpoint, the CLTX reacting with Chloride channel can be a potential chemotherapeutic 
inhibitor to stop tumor cells from proliferating.  
Extensive effort has been put on the imaging application because of its predictability 
of cancer in an earlier stage. Scientists have discovered that CLTX can target tumor cell in 
human brain with great precision. In practice, surgeons have to remove the tumor cells with 
their visual inspection that poses the risk of damaging healthy cells in the normal tissues.  
Thus, it is important to devise a method of locating and identifying the tumor cells. One of 
the promising approaches of using CLTX to detect tumor cell is ongoing. Dr. Jim Olsen 
named this potentially powerful technique as “tumor paint” [28]; because of its special ability 
of blocking Chloride channel, scientists named it as CLTX. Most importantly, it binds with 
high particular affinity to glioma and neuroectodermal tumor cells, but not with the healthy 
tissues [29]. The most challenging problem is to understand the protein-ligand binding 
mechanism which can help us resolve the off-target issue and improve its efficacy to interpret 
the interaction mechanism.  
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Another objective of this thesis is to understand how CLTX behaves in an aqueous 
environment that approximately mimics the environment of a typical drug delivery system.  
Figure 3 presents the factors accountable for the design of nanomaterial-based drug delivery 
system. Chlorotoxin plays a significant role in all the constraints factors, especially duration 
of delivery, ability to targeting and biocompatibility. Unlike micelle, liposome or gel material, 
which has hydrophobic matrix to support its structure, CLTX can resist from protease in the 
blood cell and hardly could be affected by thermal or ionic disturbances.  
Usually, there are two types of platform agents. The common one holds the drug 
agents inside of the platform geometry which can protect the drug carrier from attack by 
external force. Based on the predictions by King [12, 30], we can estimate that the four 
 
Figure 3: Factors for simultaneous consideration in the design of a nanoparticle 
for smart drug delivery system  
("Application of Nanotechnology in Drug Delivery", book edited by Ali Demir Sezer) 
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disulfide bonds in CLTX play a key role in determining the stability of the structure. More 
and more attention has been paid to the research of disulfide-rich protein in the 
pharmacological tool and therapeutics [31–33]. This thesis facilitates an understanding of the 
CLTX structure in an aqueous environment with temperature and ionic variations using 
atomistic computations.  
Computational predictions are increasingly gaining attention from researchers since 
they provide an economically feasible framework to test new theories with high resolution. 
Computational techniques can be divided into hierarchical multiscale modeling scheme based 
on the particle size scale [34], such as quantum mechanical level, molecular mechanical level 
and mesoscale level. The molecular dynamics (MD) method has emerged as a powerful 
technique for comprehension of the atomistic features of material systems. In the standard 
MD method, the Newtonian equations of motion are employed to resolve numerically the 
trajectory of the particles in a fixed periodical cell of volume V. MD simulation has three 
major types of applications [35], which are refinement of structure, descriptions of the 
system at equilibrium and examination of actual dynamics. In our work, we apply molecular 
dynamics to investigate Chlorotoxin structure in different environments, specifically, at 
different temperatures within an aqueous environment and different ions solvated in the 
solution. NAnoscale Molecular Dynamics program (NAMD) [36] and Visual Molecular 
Dynamics (VMD) [37] are utilized to simulate the atoms and to illustrate the molecular 
motion observed in the simulations. In order to obtain the results, the simulation techniques 
follow different stages: initializing to energy minimization, to energy equilibration, to 
production run.  
19 
 
 
Three structural and transport properties are employed to describe the evolution of 
CLTX due to interactions with water molecules and ions at different environments. The 
investigations of these properties educate us about the stability of the molecule as expected in 
a more complicated neighborhood of human blood flow. This provides us a reference to 
understand the possibility of transportation of therapeutic protein in blood.  
 
 
1.3 The Major Proteins on the Surface of Tumor Cells 
In order to understand the inhibitor/targeting mechanism of CLTX, we have to learn 
how tumor cells try to invade the normal tissue. Scientists have substantiated that CLTX has 
a strong correlation with tumor cells than normal brain cells [38–41]. Now there are 
numerous researchers vigorously focusing on the interaction mechanism of CLTX and tumor 
cells. Based on the current knowledge of this interaction, the tumor cell invasion mechanism 
is considered to be an extremely complex and hence important to understand, as explained in 
the literature [42]. In essence, the main aspect lies in explaining the invasion mechanism 
through the roles and functions of MMP-2 and ionic channels (Cl− and K+ channel).  
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As mentioned from above, the interaction first occurs at the surface of the tumor cells 
and normal tissues. Scientists have identified a few major proteins in the surface of tumor 
cells. They are matrix metalloprotease series (MMP-1~28), αvβ3 integrin, membrane type 2-
matrix metalloprotease (MT2-MMP), and tissue inhibitor of matrix metalloproteinase-2 
(TIMP-2). Figure 4 shows a few major proteins isolated from the surface of tumor cells. 
Because of the presence of these proteins, it is difficult to identify which major protein is the 
receptor of CLTX.  MMP-2 mainly consists primarily a 72-kda band and with five domains. 
 
Figure 4: Schematic of the MMP-integrin molecular assembly 
(Alex Strongin, Professor, Medical discovery institute) 
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The functions of these proteins are summarized in Table 3 below [40].  
 
 
1.4 Chlorotoxin and Its Receptor 
There is no conclusive evidence of the receptor that reacts with CLTX on the surface 
of tumor cells. Table 4 presents the fours receptors that can bind with CLTX. The first one is 
the Chloride channel which gives rise to the name CLTX as describe by Debin et al. in 1993. 
The second receptor is MMP-2 that is a 72-kDa band. Jessy Deshane[40] has identified 
MMP-2 as a receptor by the method of weight and also examined whether CLTX inhibits 
MMP-2 catalytic activity at this article [40]. The third receptor is Annexin A2 [43]. Annexin 
A2 is a calcium-dependent phospholipid binding protein on the extracellular side of the 
plasma membrane of various tumor cells and endothelial cell types [43]. The fourth receptor  
is the complex of the few major proteins on the surface of the tumor cells [40]. From the 
Major protein on the surface of tumor cells Function 
 
MMP-2 
In degradation and remodeling of the ECM 
αvβ3 integrin A membrane-type MMP activates MMP-2 
 
 
 
MT2-MMP 
Promotes the maturation and release of 
MMP-2; Forms a hemophilic complex 
through the hemopexin domain keeping the 
MT1-MMP molecules together facilitating 
pro-MMP-2 activation 
TIMP-2 Endogenous inhibitor 
 
Table 3: The functions of the four major proteins on the surface of the tumor cells 
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literature we can conclude that CLTX exerts some effect on the major proteins on the surface 
of the tumor cells, but we are unsure it is on individual protein MMP-2 or on the complex of 
the proteins.  
More and more evidence has proven that there is a high possibility that CLTX 
interacts with MMP-2. However, the receptor for CLTX and the mechanism underlying its 
anti-invasive effect are still unknown. In order to advance the research, it is assumed that 
MMP-2 is the receptor. Now, since the site on the MMP-2 molecule that interacts with CLTX 
is unknown, attempts are ongoing to find the active site of MMP-2 by the means of high 
accuracy equipment, such as X-ray, NMR and SEM and by the computational predictions. 
 
A more fundamental research topic is to explore the interaction of CLTX and glioma 
cell membrane, characterized by the Chloride channel and matrix metalloproteinase-2 
(MMP-2) in its morphology. MMP-2 is a protein anchoring to the glioma cell membrane.  
Since CLTX binding with glioma cells offers two functions (blockage of Chloride Channel  
  
 CLTX 
 
Receptor 1 
Small conductance CL- channels were shown to be potently 
blocked by CLTX. 
 
Receptor 2 
MMP-2 involved in ECM degradation associates with the 
interaction of CLTX and tumor cells. 
 
Receptor 3 
Annexin A2 as CLTX receptor. 
 
Receptor 4 
CLTX interacts with a combination of the major few proteins 
on the surface of tumor cells. 
 
Table 4: The possible receptors that CLTX targets  
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and attachment to MMP-2) advanced understanding of binding mechanism of CLTX reacting 
with MMP-2 can be achieved by molecular simulations. The application of such 
investigation is in the design of a biomarker to treat cancer in preoperative diagnostic and 
intraoperative pathology at cellular-level resolution.   
MMP-2 is a type of Gelatinase and its structure consists of five different domains. 
CLTX is notable of its two functions: blocking Channel and attaching to MMP-2. The 
function of MMP-2 is described by previous literature in three aspects: the ability of MMP-2 
to digest normal cell membrane, MMP-2 generated by the active agents inducing gene 
expression, and the activity of MMP-2 in destroying endogenous inhibitors. Even though the 
mechanism of glioma cells invasion of normal cells is unclear, scientists have made progress 
on the understanding of MMP relevant activities. Next, we have to obtain the complex 
coordinates (CLTX and MMP-2 binding) file (PDB), which indicates the binding site of the 
two molecules. While it is simple to obtain separate coordinates files (PDB) for both the 
molecules (CLTX and MMP-2), the complex combined coordinate file is absent to extend the 
simulation. In absence of such information about the binding sites of the two molecules, the 
computations are limited in the investigation of the interaction mechanism.  
Most of the earlier literature presents, based on experiments, a general conclusion that 
CLTX has ability to stop MMP-2 invasion. Surprisingly, there is no work using X-ray and 
NMR to investigate the interaction mechanism. It is significant for resolving the structure of 
the binding molecules by the approach of imaging. Now, it is available for the two molecule 
structures: CLTX and MMP-2, but they have an extensive surface; hence we do not know 
where the binding site is.  
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 If we do know the binding site structure coordinates, then it opens large possibilities 
to investigate interactions which can be divided into two categories: explicit and implicit. 
First is the method of Single Molecule Force Microscopy to investigate two-protein (or two 
residues, two atoms) interaction by unbinding. The magnitude of this rupture force of 
unbinding can help us decide the reaction type, such as enzymatic reaction, covalent reaction, 
noncovalent reaction or diffusive movement. It can facilitate in resolving the problems in 
drug delivery: encapsulation in transportation, controlled release and targeting bad tissue.  
Also, there is an implicit computational method to interpret the interaction 
mechanism using a statistical-thermodynamic basis. Considering the complexity of molecule, 
there are numerous articles on landscape energy, MM/PBSA and so on to calculate free 
energy.  
However, those methods have limitations. While we can employ single molecule 
force microscopy to measure the force required to unbind the bond of CLTX and MMP-2, the 
structure information from the X-Ray Crystallography and NMR data is absent. This 
prevents applying AFM to measure unbinding force or employ molecular dynamics 
simulation to compute the rupture force explicitly since it is unclear what the loading regime 
is. Moreover, since there are no experimental work reporting types of the interaction (such as 
chemical reaction, covalent, noncovalent, enzymatic, diffusely movement), choosing a 
reasonable implicit method is difficult.  
In order to apply molecular dynamics to compute the thermodynamics properties and 
interpret the interaction mechanism, some assumptions must be established. First, we will 
have no experimental data to compare with our computational work. Second, we assume the 
active site as the binding regime for the interaction. The active sites are the functional 
25 
 
 
residues as presented when the molecules interact with other particles. This will allow us to 
compute the free energy of the interaction in an implicit manner and can enlighten us of the 
interaction mechanism.  
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CHAPTER II 
FUNCTION AND APPLICATION OF CHLOROTOXIN  
 
2.1 Structure of Chlorotoxin 
CLTX purified from scorpion venom is essentially a peptide containing 36 amino 
acids and demonstrates high affinity particularly to glioma and neuroectodermal tumor [44]. 
The structure of CLTX was resolved by experimental method with the means of NMR and 
X-ray crystallography. Since the Hydrogen atom is too small, which cannot be detected by 
those tools, our computational tools have to guess those missing hydrogens.  
  A 
  
 
 
Figure 5: Amino acid sequence and 3 D representation of CLTX 
(A) The disulfide connectivity is shown using solid lines and the cysteine residue 
are labeled using Roman numerals from I to VIII [33]  
(B) 3 D structure of CLTX, α- helix in red, β -sheets in blue and disulfide bridge 
in orange 
(Jessy Deshane, The Journal of Biological Chemistry, vol. 278, No. 6) 
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While the earlier has focused on primary and secondary structures, the current interest is in 
the details of the tertiary structure. Next, we summarize the CLTX protein structure in a 
hierarchical way.  
2.1 a Primary Structure 
CLTX consisting of 36 amino acids is a protein. The amino acids sequence is shown 
in Figure 5 A. It compares with the sequence of toxin family of molecules. From the 
sequence, it is obvious that CLTX is cysteine-rich protein. 
2.1 b Secondary Structure 
Molecular structure of CLTX, α- helix in red and β-sheets in blue and Disulfide 
Bridge in orange are presented in Figure 5 B. Three are three β-sheets and one α helix. 
Scientists predict that the landscape energy of CLTX may determine the reaction mechanism 
due to such structure.  
2.1 c Tertiary Structure 
A compact structure is maintained by four disulfide bonds that connect the eight cysteine 
residues. The cysteine pattern adopted is of the type C1-C4, C2-C6, C3-C7 and C5-C8. The 
disulfide connectivity is shown using solid lines and the cysteine residues are labeled using 
Roman numerals from I to VIII in Figure 5 B. We observe that toxin family is a type of 
protein rich in cysteine. The disulfide bridges may contribute to the stability of CLTX. Figure 
6 presents a tattoo from Jim Olson who is a pioneer in imaging cancer by the use of CLTX.  
28 
 
 
                           
 
 
 
 
 
 
  
 
Figure 6: Representation of the knot of disulfide bonds 
at the center of the Chlorotoxin molecule. Jim Olson 
shows off his tattoo, which represents the knot of 
disulfide bonds at the center of the Chlorotoxin 
molecule.                Courtesy John Clark 
 
Protein: CLTX Structures features 
   
Primary Structure 
36 amino acids; the sequence and 
the α/β motif 
Secondary Structure Three α sheets and one β sheets 
Tertiary Structure Knot structure 
Quandary Structure It’s a small protein 
 
Table 5: The hierarchical structure of CLTX 
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The toxin family of molecules has three disulfide bridges in general. The CLTX, 
however, has four disulfide bridges. Earlier reports conclude that the fourth disulfide bridge 
contributes to the specific affinity of CLTX to glioma cell, since the other family members of 
toxin do not bind with glioma cell. A future area of research is to apply molecular dynamics 
to compute the free energy for the different disulfide residue to interpret CLTX functions.  
Table 5 summarizes the four level structure information of CLTX.  
 
2.2 Function and Application of Chlorotoxin 
There are two general functions of CLTX that are applicable to the pharmacy industry. 
The first one is use in therapeutic medicine. In order to penetrate the normal cells, glioma 
cells need to shrink by using ionic channels (Cl- and K+ channel).  CLTX can bind with the 
ionic channels to stop the ions communications within and outside of the glioma cells. The 
other function of CLTX is specificity and affinity.  As we have analyzed, there are four 
possible receptors reacting with CLTX and although the binding mechanism is still 
inconclusive, CLTX has shown a high efficiency to target glioma cells.  
 
  
 
 
 
 
 
 
 
 
2.3 Application of Chlorotoxin 
  
 
Function  
 
Application 
 
Structure  
 
Interact with ionic 
channel 
 
 
Therapeutic Medicine 
Essentially primary 
and secondary 
structure dominates 
determine 
Interact with four 
possible receptors and 
without knowing the 
active site of the 
receptor 
 
 
Diagnostic Medicine 
 
Unsure about how 
structure determine 
the function 
 
Table 6: Application, function and structure of Chlorotoxin 
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Based on the function of CLTX, there are also two applications of CLTX used in 
treating human diseases. Table 6 generalizes how the structure determines the function that in 
turn determines the application.  
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CHAPTER III 
 MOLECULAR SIMULATION  
 
3.1 Methodology 
In order to understand the binding mechism of CLTX and receptor, there are three 
major methods to move ahead. These are experimental method, computatonal method and 
advanced imaging. This thesis considers only the computational approach. Figure 7 presents 
examples of length scales in nature. For example, 1 Angstrom to 1 nm, ab initio first 
principles calculations such as density function theory (DFT) is applied. At the range of 10-
100 nm, classical MD simulations are employed. Larger length scales call for browinan 
dynamics (BD) simulations and course grained modeling.  
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 7: Dimensional scale of MEMS and Nanotechnology. 
(Adapted from Nguyen et al.) 
 
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
By the means of computation, researchers have applied to protein adsorption, protein 
and protein recognition, and investigate the dynamics properties of the molecules based on 
the problem requirements. In general, there are two directions in the process of 
computational drug design as shown in Figure 8. They are structure-based CADD and ligand-
based CADD.  
 
 
Fig. 8: CADD in drug discovery/design pipeline. A therapeutic target is identified 
against which a drug has to be developed. Depending on the availability of 
structure information, a structure-based approach or a ligand-based approach is 
used. A successful CADD campaign will allow identification of multiple lead 
compounds. Lead identification is often followed by several cycles of lead 
optimization and subsequent lead identification using CADD. Lead compounds 
are tested in vivo to identify drug candidates.[23] 
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3.2 Simulation details 
In order to investigate CLTX stability in water, we intentionally implement two 
parametric scenarios, temperature and ion concentration. First, the simulation is performed at 
different temperatures, 280K, 290K, 300K, and 310K, respectively. Second, the simulation at 
300 K is performed by adding three different ionic concentrations in the aqueous 
environment, 10 Na/13Cl, 50 Na/53Cl and 100 Na/103Cl. VMD is used for simulation setup, 
visualization and analyses while NAMD is employed for the simulations. There are three 
extra negative ions added for the sake of neutralizing the system. In the following 
descriptions, we use 10 ions concentration representing for 10 Na/13Cl, 50 ions representing 
for 50Na/53Cl, and 100 ions representing for 100Na/103Cl. The overall process of the 
simulation is categorized into several stages executed separately but in sequence of the 
standard protocol: EM > NVT > NPT [45][46].  
The first step is to set up the system and optimize the molecular geometry. A cubic 
box with dimension of 50 Angstrom x 50 Angstrom x 50 Angstrom contains the peptide 
CLTX. To mimic the cellular environment, the CLTX was placed in a water solvent by 
utilizing VMD Solvation Package. We generate the various concentrations of ions with the 
Autoionize Plugin. The geometry of the freely obtained protein data bank (PDB) structure 
file from the RCSB database (derived experimentally via NMR or X-ray crystallography) is 
optimized by Energy Minimization (EM). The total energy of the system evolving with step 
time is plotted in Figure 9.  
The next step is Energy Equilibration (EE). Based on Hamiltonian mechanics, the particles 
undergo energy conversion inside the system. Employing Newton’s second law, and 
CHARRM potential force field functions [47], the energy and forces of intermolecular  
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   (a)      (b) 
  
   (c) 
Figure 9: Different stages of simulation for equilibrating Chlorotoxin in water. 
Figure (a) is the indicator that total energy dropped to the system’s minimum value 
much before 20000 frames. Figure (b) presents temperature evolution with time at 
the assigned value of 310 K and shows when energy equilibration is achieved under 
the NVT ensemble.  Figure (c) shows the trend of the pressure vs. time fluctuations 
from 1 bar under the NPT ensemble. Although the average pressure agrees with the 
assigned value, the large fluctuations are due to the incompressibility effects of 
water. 
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interactions are described. The system is initialized with a velocity distribution to atoms 
corresponding to the temperature using the NVT ensemble. From the plot of the temperature 
vs. time in Figure 8, the system is found to equilibrate after about 7 ns. Then, using the last 
configuration from NVT ensemble, we continue to equilibrate the system with NPT 
ensemble. We plot pressure vs. time to identify the required equilibration time, shown in 
Figure 9.  The final stage is Production Run (PR) that employs the NPT ensemble for 10 ns. 
We analyze the molecular trajectories obtained from the PR to compute the root mean square 
deviation (RMSD), radius of gyration (Rg) and radial distribution function (RDF). The 
observed results with temperature and ion concentration dependencies are presented next 
with discussions on RMSD, Rg and RDF.  
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CHAPTER IV 
RESULTS AND DISCUSSION 
 
  
 
 
 
 
   (a)      (b) 
 
   (c)      (d) 
 
Figure 10: RMSD variation with temperature. The average difference of each 
Chlorotoxin atom position at beginning and every evolved time are calculated in 
Angstrom.    
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4.1 Predictions from simulations 
Figures 10 (a), (b), (c), and (d) are the PR results of RMSD at different temperatures. The 
aggregated differences of each CLTX atom position between the initialized time step and 
every evolved time step are calculated in Angstrom. The RMSD plots suggest that the 
peptide CLTX is most stable at 300 K as inferred from the RMSD values that become 
constant at last few nanoseconds. The reduction of RMSD in Figure 10(a) with temperature 
280 K and increment in Figure 10(b) with temperature 290 K indicate either molecule’s 
instability or that the system has not attained EE.  Under the different ion concentrations, 
from Figures 11 (a) and (b), the protein is relatively stable at 10 Na/13Cl and 50 Na/53Cl 
because of the RMSD value persists around 1 Angstrom. However, Figure 11 (c) shows the 
RMSD value increasing from 1 to 4 Angstrom that implies the mobility of the protein atoms.  
Since RMSD only concentrates on the atoms of CLTX, we cannot conjecture whether atomic 
velocities of CLTX or water molecule or ions impact on the RMSD. Hence, we cannot derive 
much detail for the interactions among CLTX, water and ions just from the RMSD analyses. 
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(a)      (b) 
 
(c) 
Figure 11: RMSD variation with ion concentration. The average difference of each 
Chlorotoxin atom position at beginning and every evolved time are calculated in 
Angstrom. 
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 While RMSD provides the information of the CLTX atoms’ displacements with time, 
Rg informs us about the expansion or compression of the whole CLTX molecule relative to 
its center of mass. Figures 12 (a), (b), (c), and (d) present the Rg value at different 
temperatures. By observing the Rg trend in all the four plots --- at 280 K it is varying 
irregularly, at 290 K it is increasing from 9.25 to 9.75 Angstrom, at 300 K it is approximately 
9.25 Angstrom and at 310 K it is fluctuating around 9.25 Angstrom regularly but with a wide 
range. As a result, temperature 300 K, Figure 12 (c), shows the relatively stable environment.   
 
 
   (a)      (b) 
 
   (c)      (d) 
Figure 12: Variation of Rg with time at different temperatures. The average distance of 
atoms of Chlorotoxin expanding or compressing corresponding to its center at different 
times is represented in Angstrom.   
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We next present the Rg results in Figure 13 for 10 Na/13Cl, 50 Na/53Cl and 100 
Na/103Cl environments. The Rg variation can be observed from the plots at different ion 
concentrations. Figure 13 (a), 10 Na/13Cl, indicates the Rg value approximated to 9.75 
Angstrom. Figure 13 (b), 50 Na/53Cl, indicates the Rg value close to 9.5 Angstrom. Figure 
13 (c), 100 Na/ 103Cl, shows the Rg value fluctuating between 9.0 and 9.75 Angstrom. 
These results imply that the protein stability decreases as the ion concentrations increases. On 
the other hand, compared ion concentrations result with temperature results of Rg, we notice 
that the values of Rg are different. This change suggests that ion concentrations contribute 
more to the CLTX stability compared to different temperature environments. Since the 
temperature environments become more complicated by adding ions, the interactions of 
CLTX atoms with other particles also become more frequent. Similar to RMSD, Rg only 
concentrates on the interaction of CLTX atoms with itself and provides no input on its 
relative interaction with water. 
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 After investigating the conformation of CLTX at varied environments by RMSD and 
Rg, we select RDF to explore the interaction of CLTX atoms with other particles, such as 
water molecules and ions. RDF measures the density of water molecule or ions 
corresponding to a reference CLTX site as a function of radial distance and Coordination 
number calculates the number of particles around CLTX as a function of radial distance. 
 
(a)      (b) 
 
(c) 
Figure 13: Variation of Rg with time at different ion concentrations. The average distance 
of atoms of Chlorotoxin expanding or compressing corresponding to its center at different 
times is represented in Angstrom.   
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Since CLTX is composed of 36 residues, it is meaningful to investigate the interaction of 
water molecules and ions surrounding each residue. Then we can discover the relatively 
active site of the protein, the hydrophobic and hydrophilic residues by using RDF. Since 
there are 36 residues in CLTX, it requires 36 RDF and CN distributions to investigate each 
residue.  
RMSD, Rg and RDF are combined to interpret the stability of CLTX. From 
investigation of RMSD, we discover that the relative stable environment is at 300 K and low 
ion concentrations. Theoretically, RMSD reflects the mobility of each of the protein atoms. 
Rg reflects the whole molecule responsiveness when the molecule is stimulated by external 
force, such as temperature determining the atom velocity and ionic forces.  Thus, it is 
significant to notice that the most stable temperature is at 300K that is between 280 K and 
310 K. The geometrical structure of the protein determines the aggregated response through 
the atoms interacting with each other.   
Figure 14 presents the peaks value of RDF and variation of CN which demonstrate 
the density of chloride, sodium and water relative to Tyrosine (TYR) at different 
environments.  We can get particle distribution between residue TYR and water and between 
residue TYR and ions. It is apparent that TYR residue has a preference to interact with 
positive ion sodium.  
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Figure 14: The RDF and variation of CN showing the density distribution of 
chloride, sodium and water relative to Tyrosine at different environments. 
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CHAPTER V 
 CONCLUSION AND FUTURE WORK  
 
Stability can be immensely useful when investigating role of CLTX transport in blood 
and ionic environment. Equilibrium molecular dynamics simulations have been performed to 
examine the stability of CLTX described by molecular structure in the solvent environment 
over a range of temperatures and salt concentrations in the solution. We have investigated 
three properties, namely, RMSD, Rg and RDF to analyze stability of CLTX at different 
temperatures and different ion concentrations. The range of varied temperature is from 280 K 
to 310 K which can provide us with details about the molecule structure. We conclude that 
the peptide CLTX is most stable at 300 K by investigating RMSD and Rg, and the TYR 
residue shows affinity towards the positively charged ions. Future efforts will be focused on 
understanding the binding mechanism between CLTX and MMR-2, and their control with 
external stimulus. 
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